U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264257) titled 'Choline and Brain Functioning in Postmenopausal Women' on Sept. 10.
Brief Summary: This study will use a randomized placebo-controlled trial to examine a single oral dose of 1650 mg choline influences brain functioning as measured by fMRI.
Study Start Date: June 15, 2022
Study Type: INTERVENTIONAL
Condition:
Menopause
Intervention:
DIETARY_SUPPLEMENT: Choline
Each subject gets one 1650 mg oral choline dose or placebo on each of two study days.
DIETARY_SUPPLEMENT: Placebo
Each subject gets one 1650 mg oral choline dose or placebo on each of two study days.
Recruitment Status: COMPLETED
Sponsor: University of Vermont
Inform...